Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

32.7B USDQ3 2026
Total value of stock positions
32.7B USD
Positions
79
Share of the ten largest
34.2%

The ten largest positions Q3 2026

  1. Taiwan Semiconductor Manufacturing (ADR) 5.4%▲ +23.2%
  2. Visa Inc. 4.7%▼ −32.6%
  3. Air Products 4.2%▲ +3.6%
  4. JPMorgan Chase 3.5%▲ +18.4%
  5. Fortive 3.3%▼ −0.6%
  6. Sherwin-Williams 2.8%▼ −27.6%
  7. Adaptive Biotechnologies Cor 2.7%unchanged
  8. MSCI 2.6%▲ +33.9%
  9. Tesla, Inc. 2.5%▲ +327.4%
  10. Mastercard 2.5%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q3 2026

Positions Q3 2026 per 13F filing, 21 of 21
Symbol Weight Shares Reported value Change Held since
V Visa Inc. 4.7% 4,307,791 1.5B USD −32.6% reduced Q3 2024 9 quarters
FTV Fortive 3.3% 19,822,919 1.1B USD −0.6% reduced Q3 2019 29 quarters
SHW Sherwin-Williams 2.8% 2,807,581 907.6M USD −27.6% reduced Q2 2024 10 quarters
AMZN Amazon 2.2% 2,922,742 728.2M USD −21.0% reduced Q4 2025 4 quarters
META Meta Platforms 2.0% 922,538 669.0M USD −50.6% reduced Q1 2026 3 quarters
Bridgebio Pharma Inc 2.0% 9,792,219 644.3M USD −1.6% reduced Q2 2019 30 quarters
TMO Thermo Fisher Scientific 1.9% 919,626 620.8M USD −52.5% reduced Q4 2025 4 quarters
DIS Walt Disney Company (The) 1.8% 5,626,566 590.2M USD −21.4% reduced Q2 2025 6 quarters
BA Boeing 1.8% 3,157,894 587.5M USD −3.6% reduced Q4 2024 8 quarters
Ferrari N V 1.7% 1,442,981 566.1M USD −34.5% reduced Q2 2026 2 quarters
Biomarin Pharmaceutical Inc 1.3% 7,173,173 430.4M USD −5.8% reduced Q4 2021 20 quarters
WAT Waters Corporation 0.7% 494,219 217.2M USD −70.3% reduced Q1 2026 3 quarters
TTWO Take-Two Interactive 0.5% 730,778 151.6M USD −22.3% reduced Q2 2026 2 quarters
Inhibrx Biosciences Inc 0.3% 1,108,008 110.9M USD −1.4% reduced Q2 2024 10 quarters
Pharvaris N V 0.3% 2,933,310 93.0M USD −19.7% reduced Q1 2021 23 quarters
Brightspring Health Svcs Inc 0.2% 1,225,597 69.6M USD −24.3% reduced Q2 2026 2 quarters
Newamsterdam Pharma Company 0.2% 2,463,911 59.9M USD −41.4% reduced Q4 2022 16 quarters
Oric Pharmaceuticals Inc 0.1% 3,562,915 48.0M USD −30.5% reduced Q1 2024 11 quarters
Ginkgo Bioworks Holdings Inc 0.1% 2,900,025 37.2M USD −18.9% reduced Q3 2024 9 quarters
Trevi Therapeutics Inc < 0.1% 1,031,644 14.8M USD −33.2% reduced Q3 2022 17 quarters
Oruka Therapeutics Inc < 0.1% 58,000 4.8M USD −96.1% reduced Q3 2025 5 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 18.4%
  • Industrials 11.9%
  • Consumer Discretionary 11.3%
  • Technology 8.0%
  • Materials 7.0%
  • Communication Services 6.1%
  • Real Estate 5.9%
  • Health Care 4.2%
  • not in our coverage 27.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

Follow as a favorites list

With a free account you can turn the 44 stocks of this portfolio that we cover into your own favorites list.

Add to a favorites list Log in

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close